Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Aug-23 4:06 PM View:  | Jerel Davis Director | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 3,035,210 | -- | -- | (100%) 3.04M to 0 | |
| 11-Aug-23 4:04 PM View: | Akkaraju Srinivas Director | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 3,300 | -- | -- | (< 1%) 5.17M to 5.16M | |
| 11-Aug-23 4:08 PM View: | Greenman William Mariner Director | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 23,643 | -- | -- | (100%) 23.64K to 0 | |
| 11-Aug-23 4:09 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 19,157 | -- | -- | (100%) 19.16K to 0 | |
| 11-Aug-23 4:07 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 301,138 | -- | -- | (100%) 301.14K to 0 | |
| 11-Aug-23 4:07 PM View: | Frohlich Tom Chief Operating Officer | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 150,777 | -- | -- | (100%) 150.78K to 0 | |
| 11-Aug-23 4:10 PM View: | Krishnan Mahesh Director | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 1,275 | -- | -- | (100%) 1.27K to 0 | |
| 11-Aug-23 4:04 PM View: | Akkaraju Srinivas Director | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 5,161,890 | -- | -- | (100%) 5.16M to 0 | |
| 11-Aug-23 4:06 PM View: | Jerel Davis Director | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 447,013 | -- | -- | (13%) 3.48M to 3.04M | |
| 11-Aug-23 4:09 PM View: | Burris Michelle Director | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 3,300 | -- | -- | (100%) 3.3K to 0 | |
| 11-Aug-23 4:11 PM View: | Thomas Dolca Director | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 13,300 | -- | -- | (100%) 13.3K to 0 | |
| 11-Aug-23 4:05 PM View: | Bjerkholt Eric Chief Financial Officer | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 39,371 | -- | -- | (100%) 39.37K to 0 | |
| 01-Aug-23 7:27 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 01-Aug-23 | Option Sale | 1,168 | $39.03 | $45,585.90 | (6%) 20.32K to 19.16K | |
| 01-Aug-23 7:27 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 29-Jul-23 | Option Exercise | 3,333 | -- | -- | 20% 16.99K to 20.32K | |
| 31-May-23 7:26 PM View: | Greenman William Mariner Director | Chinook Therapeutics, Inc. (KDNY) | 30-May-23 | Option Sale | 1,155 | $23.30 | $26,911.50 | (5%) 24.8K to 23.64K | |
| 31-May-23 7:24 PM View: | Haghighat Ross Director | Chinook Therapeutics, Inc. (KDNY) | 26-May-23 | Option Exercise | 3,300 | -- | -- | 3% 121.25K to 124.55K | |
| 31-May-23 7:23 PM View: | Burris Michelle Director | Chinook Therapeutics, Inc. (KDNY) | 26-May-23 | Option Exercise | 3,300 | -- | -- | 100% 0 to 3.3K | |
| 31-May-23 7:21 PM View: | Thomas Dolca Director | Chinook Therapeutics, Inc. (KDNY) | 26-May-23 | Option Exercise | 3,300 | -- | -- | 33% 10.0K to 13.3K | |
| 31-May-23 7:22 PM View: | Jerel Davis Director | Chinook Therapeutics, Inc. (KDNY) | 26-May-23 | Option Exercise | 3,300 | -- | -- | < 1% 730.47K to 733.77K | |
| 31-May-23 7:26 PM View: | Greenman William Mariner Director | Chinook Therapeutics, Inc. (KDNY) | 26-May-23 | Option Exercise | 3,300 | -- | -- | 15% 21.5K to 24.8K | |
| 31-May-23 7:25 PM View: | Akkaraju Srinivas Director | Chinook Therapeutics, Inc. (KDNY) | 26-May-23 | Option Exercise | 3,300 | -- | -- | 100% 0 to 3.3K | |
| 26-Apr-23 5:19 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 24-Apr-23 | Planned Option Sale | 1,200 | $22.26 | $26,711.00 | < 1% 323.74K to 324.94K | |
| 26-Apr-23 5:19 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 24-Apr-23 | Planned Option Sale | 23,800 | $21.58 | $513,528.00 | (7%) 324.94K to 301.14K | |
| 26-Apr-23 5:19 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 24-Apr-23 | Option Exercise | 25,000 | $0.42 | $10,500.00 | 8% 298.74K to 323.74K | |
| 19-Apr-23 5:58 PM View: | Jerel Davis Director | Chinook Therapeutics, Inc. (KDNY) | 17-Apr-23 | Private Sale | 295,808 | $20.75 | $6,138,220.00 | (8%) 3.77M to 3.48M | |
| 04-Apr-23 9:14 PM View: | Krishnan Mahesh Director | Chinook Therapeutics, Inc. (KDNY) | 04-Apr-23 | Planned Option Sale | 924 | $23.01 | $21,261.20 | (42%) 2.2K to 1.27K | |
| 05-Apr-23 4:43 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 03-Apr-23 | Option Exercise | 2,500 | $0.35 | $875.00 | 13% 19.49K to 21.99K | |
| 05-Apr-23 4:43 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 03-Apr-23 | Sale (Planned) | 2,500 | $23.34 | $58,358.80 | (13%) 19.49K to 16.99K | |
| 05-Apr-23 4:43 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 03-Apr-23 | Planned Option Sale | 2,500 | $23.34 | $58,358.80 | (11%) 21.99K to 19.49K | |
| 04-Apr-23 9:14 PM View: | Krishnan Mahesh Director | Chinook Therapeutics, Inc. (KDNY) | 01-Apr-23 | Option Exercise | 2,199 | -- | -- | 100% 0 to 2.2K | |
| 03-Mar-23 4:13 PM View: | Jerel Davis Director | Chinook Therapeutics, Inc. (KDNY) | 01-Mar-23 | Private Sale | 400,000 | $22.75 | $9,100,000.00 | (10%) 4.17M to 3.77M | |
| 15-Feb-23 4:40 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 10-Feb-23 | Option Sale | 8,097 | $23.75 | $192,292.00 | (3%) 309.24K to 301.14K | |
| 15-Feb-23 4:40 PM View: | Frohlich Tom Chief Operating Officer | Chinook Therapeutics, Inc. (KDNY) | 10-Feb-23 | Option Sale | 3,700 | $23.75 | $87,869.50 | (2%) 154.48K to 150.78K | |
| 15-Feb-23 4:40 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 10-Feb-23 | Option Exercise | 20,248 | -- | -- | 7% 288.99K to 309.24K | |
| 15-Feb-23 4:40 PM View: | Frohlich Tom Chief Operating Officer | Chinook Therapeutics, Inc. (KDNY) | 10-Feb-23 | Option Exercise | 6,803 | -- | -- | 5% 147.67K to 154.48K | |
| 15-Feb-23 4:39 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 10-Feb-23 | Option Sale | 2,392 | $23.75 | $56,806.40 | (11%) 21.88K to 19.49K | |
| 15-Feb-23 4:41 PM View: | Bjerkholt Eric Chief Financial Officer | Chinook Therapeutics, Inc. (KDNY) | 10-Feb-23 | Option Exercise | 2,435 | -- | -- | 7% 37.29K to 39.72K | |
| 15-Feb-23 4:41 PM View: | Bjerkholt Eric Chief Financial Officer | Chinook Therapeutics, Inc. (KDNY) | 10-Feb-23 | Option Sale | 857 | $23.75 | $20,352.50 | (2%) 39.72K to 38.87K | |
| 15-Feb-23 4:39 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 10-Feb-23 | Option Exercise | 6,803 | -- | -- | 45% 15.08K to 21.88K | |
| 01-Feb-23 8:32 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 31-Jan-23 | Option Exercise | 24,999 | -- | -- | 9% 271.68K to 296.68K | |
| 02-Feb-23 6:15 PM View: | Frohlich Tom Chief Operating Officer | Chinook Therapeutics, Inc. (KDNY) | 31-Jan-23 | Option Exercise | 8,333 | -- | -- | 6% 143.91K to 152.24K | |
| 02-Feb-23 6:13 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 31-Jan-23 | Option Sale | 3,244 | $24.68 | $80,069.10 | (18%) 18.32K to 15.08K | |
| 02-Feb-23 6:14 PM View: | Bjerkholt Eric Chief Financial Officer | Chinook Therapeutics, Inc. (KDNY) | 31-Jan-23 | Option Exercise | 7,333 | -- | -- | 22% 32.85K to 40.18K | |
| 02-Feb-23 6:14 PM View: | Bjerkholt Eric Chief Financial Officer | Chinook Therapeutics, Inc. (KDNY) | 31-Jan-23 | Option Sale | 2,891 | $24.68 | $71,356.50 | (7%) 40.18K to 37.29K | |
| 02-Feb-23 6:13 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 31-Jan-23 | Option Exercise | 8,333 | -- | -- | 83% 9.99K to 18.32K | |
| 01-Feb-23 8:32 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 31-Jan-23 | Option Sale | 7,688 | $24.68 | $189,757.00 | (3%) 296.68K to 288.99K | |
| 02-Feb-23 6:15 PM View: | Frohlich Tom Chief Operating Officer | Chinook Therapeutics, Inc. (KDNY) | 31-Jan-23 | Option Sale | 4,566 | $24.68 | $112,700.00 | (3%) 152.24K to 147.67K | |
| 01-Feb-23 8:32 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 30-Jan-23 | Planned Option Sale | 25,000 | $24.54 | $613,612.00 | (8%) 296.68K to 271.68K | |
| 01-Feb-23 8:32 PM View: | Dobmeier Eric President, CEO Director | Chinook Therapeutics, Inc. (KDNY) | 30-Jan-23 | Option Exercise | 25,000 | $0.42 | $10,500.00 | 9% 271.68K to 296.68K | |
| 04-Jan-23 7:44 PM View: | King Andrew James Chief Scientific Officer | Chinook Therapeutics, Inc. (KDNY) | 03-Jan-23 | Planned Option Sale | 7,500 | $25.82 | $193,637.00 | (38%) 19.99K to 12.49K |
